226 related articles for article (PubMed ID: 33325655)
21. Effects of postoperative chemotherapy and radiotherapy on patients with squamous cell carcinoma of the oral cavity and multiple regional lymph node metastases.
Takahashi H; Yanamoto S; Yamada S; Umeda M; Shigeta T; Minamikawa T; Shibuya Y; Komori T; Shiraishi T; Asahina I; Yokoo S; Ri S
Int J Oral Maxillofac Surg; 2014 Jun; 43(6):680-5. PubMed ID: 24387949
[TBL] [Abstract][Full Text] [Related]
22. Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma.
Zubair F; McMahon J; Kryklyas G; Wicks C
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):589-595. PubMed ID: 35248409
[TBL] [Abstract][Full Text] [Related]
23. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
[TBL] [Abstract][Full Text] [Related]
24. The predictive value of systemic immune inflammation index for postoperative survival of gallbladder carcinoma patients.
Chen H; Huang Z; Sun B; Wang A; Wang Y; Shi H; Zheng T; Li T; Huang M; Fu W
J Surg Oncol; 2021 Jul; 124(1):59-66. PubMed ID: 33765331
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer.
Murthy P; Zenati MS; Al Abbas AI; Rieser CJ; Bahary N; Lotze MT; Zeh HJ; Zureikat AH; Boone BA
Ann Surg Oncol; 2020 Mar; 27(3):898-906. PubMed ID: 31792715
[TBL] [Abstract][Full Text] [Related]
26. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
27. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
[TBL] [Abstract][Full Text] [Related]
28. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx.
Glaser CM; Millesi W; Kornek GV; Lang S; Schüll B; Watzinger F; Selzer E; Lavey RS
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):705-15. PubMed ID: 11395239
[TBL] [Abstract][Full Text] [Related]
29. Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity.
Elbers JBW; Al-Mamgani A; Paping D; van den Brekel MWM; Jóźwiak K; de Boer JP; Karakullukcu B; Verheij M; Zuur CL
Oral Oncol; 2017 Dec; 75():163-168. PubMed ID: 29224815
[TBL] [Abstract][Full Text] [Related]
30. Significance of a preoperative systemic immune-inflammation index as a predictor of postoperative survival outcomes in gastric cancer.
Inoue H; Kosuga T; Kubota T; Konishi H; Shiozaki A; Okamoto K; Fujiwara H; Otsuji E
World J Surg Oncol; 2021 Jun; 19(1):173. PubMed ID: 34118953
[TBL] [Abstract][Full Text] [Related]
31. Multi-center retrospective study of the prognosis and treatment outcomes of Japanese oral squamous cell carcinoma patients with single lymph node metastasis and extra nodal extension.
Hasegawa T; Yanamoto S; Otsuru M; Kakei Y; Okura M; Yamakawa N; Yamada SI; Ota Y; Umeda M; Kirita T; Kurita H; Ueda M; Komori T;
J Surg Oncol; 2018 Jun; 117(8):1736-1743. PubMed ID: 29714825
[TBL] [Abstract][Full Text] [Related]
32. High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer.
Perisanidis C; Kornek G; Pöschl PW; Holzinger D; Pirklbauer K; Schopper C; Ewers R
Med Oncol; 2013 Mar; 30(1):334. PubMed ID: 23292862
[TBL] [Abstract][Full Text] [Related]
33. High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy.
Wang C; Jin S; Xu S; Cao S
Lung; 2020 Apr; 198(2):405-414. PubMed ID: 32016563
[TBL] [Abstract][Full Text] [Related]
34. Association of Postoperative Radiotherapy With Survival in Patients With N1 Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
Chen MM; Harris JP; Hara W; Sirjani D; Divi V
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1224-1230. PubMed ID: 27832255
[TBL] [Abstract][Full Text] [Related]
35. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
36. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer.
Valero C; Zanoni DK; McGill MR; Ganly I; Morris LGT; Quer M; Shah JP; Wong RJ; León X; Patel SG
Cancer; 2020 Mar; 126(5):994-1003. PubMed ID: 31809562
[TBL] [Abstract][Full Text] [Related]
38. Distant Metastases Following Postoperative Intensity-Modulated Radiotherapy for Oral Cavity Squamous Cell Carcinoma.
Hosni A; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; De Almeidad J; O'Sullivan B; Goldstein D; Hope A
JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):368-375. PubMed ID: 28033442
[TBL] [Abstract][Full Text] [Related]
39. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
